152 related articles for article (PubMed ID: 17084966)
1. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.
Temme A; Rodriguez JA; Hendruschk S; Günes S; Weigle B; Schäkel K; Schmitz M; Bachmann M; Schackert G; Rieber EP
Cancer Lett; 2007 Jun; 250(2):177-93. PubMed ID: 17084966
[TBL] [Abstract][Full Text] [Related]
2. Nuclear export is essential for the tumor-promoting activity of survivin.
Knauer SK; Krämer OH; Knösel T; Engels K; Rödel F; Kovács AF; Dietmaier W; Klein-Hitpass L; Habtemichael N; Schweitzer A; Brieger J; Rödel C; Mann W; Petersen I; Heinzel T; Stauber RH
FASEB J; 2007 Jan; 21(1):207-16. PubMed ID: 17099069
[TBL] [Abstract][Full Text] [Related]
3. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
[TBL] [Abstract][Full Text] [Related]
4. Nuclear targeting of Bax during apoptosis in human colorectal cancer cells.
Mandal M; Adam L; Mendelsohn J; Kumar R
Oncogene; 1998 Aug; 17(8):999-1007. PubMed ID: 9747879
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor.
Aqeilan R; Kedar R; Ben-Yehudah A; Lorberboum-Galski H
Biochem J; 2003 Feb; 370(Pt 1):129-40. PubMed ID: 12405905
[TBL] [Abstract][Full Text] [Related]
6. Differential subcellular localization of functionally divergent survivin splice variants.
Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
[TBL] [Abstract][Full Text] [Related]
7. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
Zhang H
Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of survivin by p53 contributes to cell cycle dependent apoptosis.
Jin Y; Wei Y; Xiong L; Yang Y; Wu JR
Cell Res; 2005 May; 15(5):361-70. PubMed ID: 15916722
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells.
Fukada K; Takahashi-Yanaga F; Sakoguchi-Okada N; Shiraishi F; Miwa Y; Morimoto S; Sasaguri T
Biochem Biophys Res Commun; 2007 Jun; 357(4):1166-71. PubMed ID: 17466271
[TBL] [Abstract][Full Text] [Related]
11. No prognostic impact of survivin expression in glioblastoma.
Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
[TBL] [Abstract][Full Text] [Related]
12. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
[TBL] [Abstract][Full Text] [Related]
13. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
14. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.
Zhu N; Gu L; Findley HW; Li F; Zhou M
Oncogene; 2004 Sep; 23(45):7545-51. PubMed ID: 15334064
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
16. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
17. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.
Stauber RH; Mann W; Knauer SK
Cancer Res; 2007 Jul; 67(13):5999-6002. PubMed ID: 17616652
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
19. Cloning and functional characterization of the guinea pig apoptosis inhibitor protein Survivin.
Habtemichael N; Wünsch D; Bier C; Tillmann S; Unruhe B; Frauenknecht K; Heinrich UR; Mann WJ; Stauber RH; Knauer SK
Gene; 2010 Dec; 469(1-2):9-17. PubMed ID: 20727954
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
